IL135581A0 - Novel use of compounds for anti-pruritic activity - Google Patents
Novel use of compounds for anti-pruritic activityInfo
- Publication number
- IL135581A0 IL135581A0 IL13558198A IL13558198A IL135581A0 IL 135581 A0 IL135581 A0 IL 135581A0 IL 13558198 A IL13558198 A IL 13558198A IL 13558198 A IL13558198 A IL 13558198A IL 135581 A0 IL135581 A0 IL 135581A0
- Authority
- IL
- Israel
- Prior art keywords
- compounds
- novel use
- pruritic activity
- pruritic
- activity
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6374697P | 1997-10-17 | 1997-10-17 | |
| PCT/US1998/021886 WO1999020280A1 (en) | 1997-10-17 | 1998-10-16 | Novel use of compounds for anti-pruritic activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL135581A0 true IL135581A0 (en) | 2001-05-20 |
Family
ID=22051225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13558198A IL135581A0 (en) | 1997-10-17 | 1998-10-16 | Novel use of compounds for anti-pruritic activity |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1030666A4 (xx) |
| JP (1) | JP2001520196A (xx) |
| KR (1) | KR20010031149A (xx) |
| CN (1) | CN1306426A (xx) |
| AR (1) | AR015966A1 (xx) |
| AU (1) | AU740875B2 (xx) |
| BR (1) | BR9814080A (xx) |
| CA (1) | CA2306985A1 (xx) |
| CO (1) | CO4810374A1 (xx) |
| CZ (1) | CZ20001376A3 (xx) |
| HU (1) | HUP0003792A3 (xx) |
| IL (1) | IL135581A0 (xx) |
| NO (1) | NO20001847L (xx) |
| NZ (1) | NZ503551A (xx) |
| PL (1) | PL341062A1 (xx) |
| TR (1) | TR200001040T2 (xx) |
| WO (1) | WO1999020280A1 (xx) |
| ZA (1) | ZA989450B (xx) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7250518B2 (en) | 2001-01-31 | 2007-07-31 | Pfizer Inc. | Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes |
| MXPA03006885A (es) | 2001-01-31 | 2003-11-13 | Pfizer Prod Inc | Derivados de eteres utiles como agentes inhibidores de las isozimas pde4. |
| BR0116852A (pt) | 2001-01-31 | 2004-02-25 | Pfizer Prod Inc | Derivados biarilados de nicotinamida úteis como inibidores de isozimas pde4 |
| PL365443A1 (en) | 2001-01-31 | 2005-01-10 | Pfizer Products Inc. | Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
| US20030175314A1 (en) * | 2001-11-19 | 2003-09-18 | Didriksen Erik Johannes | Pharmaceutical composition for dermal application |
| WO2005007161A1 (ja) * | 2003-07-17 | 2005-01-27 | Santen Pharmaceutical Co., Ltd. | ピペリジン誘導体を有効成分とする掻痒治療剤 |
| WO2005053672A1 (ja) * | 2003-12-04 | 2005-06-16 | Santen Pharmaceutical Co., Ltd. | シロミラストまたはその塩を有効成分とする掻痒治療剤 |
| JP2005187458A (ja) * | 2003-12-04 | 2005-07-14 | Santen Pharmaceut Co Ltd | シロミラストまたはその塩を有効成分とする掻痒治療剤 |
| WO2005077950A2 (en) * | 2004-02-14 | 2005-08-25 | Smithkline Beecham Corporation | Medicaments with hm74a receptor activity |
| JP2008137892A (ja) * | 2005-03-04 | 2008-06-19 | Eisai Co Ltd | 止痒剤 |
| WO2007017262A1 (en) | 2005-08-10 | 2007-02-15 | Smithkline Beecham Corporation | Xanthine derivatives as selective hm74a agonists |
| TWI404709B (zh) * | 2006-02-21 | 2013-08-11 | Eisai R&D Man Co Ltd | 4- (3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives |
| CA2637573C (en) * | 2006-02-21 | 2013-07-02 | Eisai R&D Management Co., Ltd. | 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives |
| AU2008215411B2 (en) | 2007-02-16 | 2012-11-22 | Eisai R & D Management Co., Ltd. | Crystal, amorphous form and salt of methyl N-[3-(6,7-dimethoxy- 2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid |
| WO2009025239A1 (ja) | 2007-08-17 | 2009-02-26 | Eisai R & D Management Co., Ltd. | 新規外用剤 |
| ATE538102T1 (de) | 2007-08-17 | 2012-01-15 | Eisai R&D Man Co Ltd | Verfahren zur herstellung eines chinazolinderivats |
| JP5985475B2 (ja) * | 2011-06-28 | 2016-09-06 | 田辺三菱製薬株式会社 | 新規医薬組成物 |
| BR112017016065A2 (pt) | 2015-01-30 | 2018-04-03 | Shanton Pharma Co., Ltd. | prevenção ou tratamento de ácido úrico ou doença gotosa |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69132291T2 (de) * | 1990-12-21 | 2000-12-14 | Beecham Group P.L.C., Brentford | Xanthinderivate |
| PT889886E (pt) * | 1996-03-26 | 2003-02-28 | Altana Pharma Ag | Novas fenantridinas substituidas na posicao 6 |
| WO1997043288A1 (en) * | 1996-05-15 | 1997-11-20 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Novel imidazopyridines |
| PT968211E (pt) * | 1997-03-07 | 2004-01-30 | Altana Pharma Ag | Derivados de tetrazoles |
| CA2282845A1 (en) * | 1997-03-18 | 1998-09-24 | Basf Aktiengesellschaft | Methods and compositions for modulating responsiveness to corticosteroids |
| DK0988302T3 (da) * | 1997-06-03 | 2003-06-02 | Altana Pharma Ag | Benzonaphthyridiner |
-
1998
- 1998-10-15 AR ARP980105131A patent/AR015966A1/es not_active Application Discontinuation
- 1998-10-16 HU HU0003792A patent/HUP0003792A3/hu unknown
- 1998-10-16 ZA ZA989450A patent/ZA989450B/xx unknown
- 1998-10-16 IL IL13558198A patent/IL135581A0/xx unknown
- 1998-10-16 EP EP98953608A patent/EP1030666A4/en not_active Withdrawn
- 1998-10-16 PL PL98341062A patent/PL341062A1/xx unknown
- 1998-10-16 AU AU10938/99A patent/AU740875B2/en not_active Ceased
- 1998-10-16 KR KR1020007004053A patent/KR20010031149A/ko not_active Application Discontinuation
- 1998-10-16 CN CN98810066A patent/CN1306426A/zh active Pending
- 1998-10-16 JP JP2000516677A patent/JP2001520196A/ja not_active Withdrawn
- 1998-10-16 CO CO98060225A patent/CO4810374A1/es unknown
- 1998-10-16 BR BR9814080-9A patent/BR9814080A/pt not_active IP Right Cessation
- 1998-10-16 CA CA002306985A patent/CA2306985A1/en not_active Abandoned
- 1998-10-16 CZ CZ20001376A patent/CZ20001376A3/cs unknown
- 1998-10-16 TR TR2000/01040T patent/TR200001040T2/xx unknown
- 1998-10-16 WO PCT/US1998/021886 patent/WO1999020280A1/en not_active Application Discontinuation
- 1998-10-16 NZ NZ503551A patent/NZ503551A/en unknown
-
2000
- 2000-04-10 NO NO20001847A patent/NO20001847L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999020280A1 (en) | 1999-04-29 |
| HUP0003792A2 (hu) | 2001-10-28 |
| NZ503551A (en) | 2002-05-31 |
| AR015966A1 (es) | 2001-05-30 |
| CN1306426A (zh) | 2001-08-01 |
| CZ20001376A3 (cs) | 2002-06-12 |
| AU740875B2 (en) | 2001-11-15 |
| KR20010031149A (ko) | 2001-04-16 |
| HUP0003792A3 (en) | 2001-12-28 |
| EP1030666A1 (en) | 2000-08-30 |
| PL341062A1 (en) | 2001-03-26 |
| CO4810374A1 (es) | 1999-06-30 |
| BR9814080A (pt) | 2000-09-26 |
| CA2306985A1 (en) | 1999-04-29 |
| ZA989450B (en) | 1999-04-19 |
| TR200001040T2 (tr) | 2001-01-22 |
| JP2001520196A (ja) | 2001-10-30 |
| EP1030666A4 (en) | 2002-10-16 |
| NO20001847D0 (no) | 2000-04-10 |
| NO20001847L (no) | 2000-04-10 |
| AU1093899A (en) | 1999-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1025322A1 (en) | Novel spiroazabicyclic heterocyclic compounds | |
| HUP0003792A3 (en) | Novel use of compounds for anti-pruritic activity | |
| EG24177A (en) | Novel compounds | |
| CZ219999A3 (cs) | Nové sloučeniny s analgetickým účinkem | |
| PL340400A1 (en) | 2-phenyl-substituted imidazotriazinones as inhibitors of phosphodiesterase | |
| IL132170A0 (en) | Novel heterocyclic compounds | |
| CZ220099A3 (cs) | Nové sloučeniny s analgetickým účinkem | |
| PL337738A1 (en) | Novel substituted compounds of imidazole | |
| GB9706255D0 (en) | Novel compounds | |
| PL338791A1 (en) | Compounds exhibiting neuronic activity | |
| IL113248A0 (en) | Use of alpha - 1c specific compounds | |
| IL125840A0 (en) | Production of bromine compounds | |
| PL327732A1 (en) | Compounds of therapeutic activity | |
| GB9701674D0 (en) | Use of organic compounds | |
| ZA981920B (en) | Novel heterocyclic compounds | |
| HU9800373D0 (en) | Steroide compounds of anticeptive and antiosteoporosive activity | |
| PL327538A1 (en) | Novel compounds of analgesic activity | |
| PL339673A1 (en) | Novel compounds suitable for use as neuroprotective agents | |
| ZA985448B (en) | Novel heterocyclic compounds | |
| HU9700442D0 (en) | Compounds of pharmaceutical activity | |
| AUPP059897A0 (en) | New use of bicozamycin | |
| GB9722026D0 (en) | Use of compounds | |
| SI1121108T1 (en) | Novel therapeutic use of compounds with beta-3-agonist activity | |
| ZA985449B (en) | Novel heterocyclic compounds | |
| HU9701917D0 (en) | New compound of medicinal activity |